Method for monitoring the viability of a graft
AssigneeHemarina
InventorFranck ZAL
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for monitoring the oxygenation of a graft, comprising: a) mixing an organ storage solution preferably with at least one molecule chosen from extracellular hemoglobin from annelids, its globins and its globin protomers, in order to obtain a composition, in a sealed container; b) immersion of the graft in the composition obtained in a); c) the introduction of an oxygen probe in the composition obtained in a), or in the composition of step b); and d) the closure of the hermetic container, steps c) and d) being carried out simultaneously or in any order. It also relates to a method for determining the viability of a graft.
Claims18
Method of monitoring the oxygenation of a graft, comprising:
- a) providing an organ storage solution and mixing the organ storage solution with at least one oxygen carrier, to obtain a composition, in a sealed container,
- b) immersing the graft in the composition obtained in step a) to obtain a second composition;
- c) introducing an oxygen probe in the composition obtained in a), and/or in the second composition of step b);
- and
- d) hermetically closing the sealed container, steps c) and d) being carried out simultaneously or in any order.
(canceled)
Method of determining the viability of a graft comprising:
- (i) providing an organ-storage solution with at least one oxygen carrier, in order to obtain a composition, in a sealed container;
- (ii) immersing the graft in the composition obtained in (i) to obtain a second composition;
- (iii) introducing an oxygen probe in the composition obtained in (i), and/or in the second composition of step (ii);
- (iv) closing the sealed container, steps (iii) and (iv) being carried out simultaneously or in any order;
- then
- (v) transporting the sealed container, to the place of transplantation of the graft to a recipient,
- vi) during steps ii) to v), monitoring the dissolved oxygen in the second composition, wherein the amount of dissolved oxygen indicates the viability of the graft.
Dependencies are inferred from the claim text.